- Home
- MGX vs BANX Comparison
MGX vs BANX Comparison
Compare MGX & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- BANX
- Stock Information
- Founded
- MGX 2018
- BANX 2013
- Country
- MGX United States
- BANX United States
- Employees
- MGX N/A
- BANX N/A
- Industry
- MGX
- BANX Trusts Except Educational Religious and Charitable
- Sector
- MGX
- BANX Finance
- Exchange
- MGX NYSE
- BANX Nasdaq
- Market Cap
- MGX 150.1M
- BANX 147.8M
- IPO Year
- MGX 2024
- BANX N/A
- Fundamental
- Price
- MGX $2.61
- BANX $21.18
- Analyst Decision
- MGX Strong Buy
- BANX
- Analyst Count
- MGX 7
- BANX 0
- Target Price
- MGX $16.67
- BANX N/A
- AVG Volume (30 Days)
- MGX 1.0M
- BANX 27.2K
- Earning Date
- MGX 02-12-2025
- BANX 03-05-2025
- Dividend Yield
- MGX N/A
- BANX 9.44%
- EPS Growth
- MGX N/A
- BANX 29.76
- EPS
- MGX N/A
- BANX 2.61
- Revenue
- MGX $55,080,000.00
- BANX $29,948,603.00
- Revenue This Year
- MGX $16.91
- BANX N/A
- Revenue Next Year
- MGX N/A
- BANX N/A
- P/E Ratio
- MGX N/A
- BANX $8.10
- Revenue Growth
- MGX 45.13
- BANX 18.11
- 52 Week Low
- MGX $1.61
- BANX $17.81
- 52 Week High
- MGX $12.74
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- MGX 39.42
- BANX 57.27
- Support Level
- MGX $2.67
- BANX $20.30
- Resistance Level
- MGX $4.06
- BANX $21.03
- Average True Range (ATR)
- MGX 0.31
- BANX 0.36
- MACD
- MGX -0.16
- BANX -0.01
- Stochastic Oscillator
- MGX 2.62
- BANX 75.21
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds, and others.